Our colleagues at the InsideMedicalDevices blog have posted a short summary of two draft guidance documents recently issued by the FDA pertaining to internet/social media. The first draft guidance document discusses how manufacturers of drugs, biological products, and medical devices should respond to misinformation about their products posted by third parties on internet/social media platforms. The second document focuses on the presentation of information on electronic/digital platforms that have character space limitations.
